Delivery Order SPE2DR25D1106-SPE2DR26FJB5E
- Not listed
- The Defense Logistics Agency awarded a $5,239.50 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with a completion date of June 30, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $12,016.38 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents under a firm fixed price contract, with performance in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $1,047.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of September 12, 2025. This non-set-aside competitive award represents a single delivery order fulfillment under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $1,908.02 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with performance in Conshohocken, Pennsylvania and completion targeted for November 26, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively on November 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a $10,479 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of September 24, 2025. This competitively awarded, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $5,249.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Rabavert rabies vaccine with diluents. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 7, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor in the federal medical procurement supply chain, particularly for...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $28,406.00 for Rabavert rabies vaccine with diluents, with performance at the company's facility in Conshohocken, Pennsylvania. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 5, 2025. The delivery order represents a specific transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,341.20 to AmerisourceBergen Drug Corp for Rabavert Rabies Vaccine with diluents, with performance in Conshohocken, Pennsylvania. This firm fixed-price delivery order, awarded on August 15, 2025, represents a non-competitive procurement and is scheduled for completion by August 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,770.60 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with a completion date of December 9, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor on this order. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $6,297.80 firm fixed price delivery order for Rabavert rabies vaccine with diluents, effective August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJB5EDelivery Order
The Defense Logistics Agency awarded a $5,251.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Rabavert rabies vaccine with diluents, with performance in Conshohocken, Pennsylvania and an ultimate completion date of December 2, 2025. This contract was awarded competitively with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime contract vehicle running through December 2026 that provides comprehensive global pharmaceutical support. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies, including vaccines, specialty medications, and medical devices, to support military healthcare programs and other government healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 11/30/25 |